Similar Efficacy with Omalizumab in Chronic Idiopathic/Spontaneous Urticaria Despite Different Background Therapy-Reference-Cited by-同舟云学术

Similar Efficacy with Omalizumab in Chronic Idiopathic/Spontaneous Urticaria Despite Different Background Therapy

Published:2015-09 Issue:5 Volume:3 Page:743-750.e1
ISSN:2213-2198
Container-title:The Journal of Allergy and Clinical Immunology: In Practice
language:en
Short-container-title:The Journal of Allergy and Clinical Immunology: In Practice

Author:

Casale Thomas B.,Bernstein Jonathan A.,Maurer Marcus,Saini Sarbjit S.,Trzaskoma Benjamin,Chen Hubert,Grattan Clive E.,Gimenéz-Arnau Ana,Kaplan Allen P.,Rosén Karin

Publisher

Elsevier BV

Subject

Immunology and Allergy

Reference21 articles.

1. The EAACI/GA(2) LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update;Zuberbier;Allergy,2014

2. Chronic unremitting urticaria: is the use of antihistamines above the licensed dose effective? A preliminary study of cetirizine at licensed and above-licensed doses;Asero;Clin Exp Dermatol,2007

3. Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyroperoxidase;Maurer;J Allergy Clin Immunol,2011

4. The effectiveness of levocetirizine and desloratadine in up to 4 times conventional doses in difficult-to-treat urticaria;Staevska;J Allergy Clin Immunol,2010

5. Alternative agents in refractory chronic urticaria: evidence and considerations on their selection and use;Khan;J Allergy Clin Immunol Pract,2013

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Does angioedema in patients with chronic spontaneous urticaria impact response to omalizumab?;World Allergy Organization Journal;2024-08

2. Chronic Spontaneous Urticaria;Immunology and Allergy Clinics of North America;2024-08

3. The future of targeted therapy in chronic spontaneous urticaria;Annals of Allergy, Asthma & Immunology;2024-06

4. How relevant are eosinophils to chronic spontaneous urticaria? No evidence of clinical benefit from eosinophil depletion with benralizumab;British Journal of Dermatology;2024-04-22

5. Risk calculator of the clinical response to antihistamines in chronic urticaria: Development and internal validation;PLOS ONE;2024-02-23